openPR Logo
Press release

SGLT2 Inhibitors Treatment Market Current and Future Industry Landscape Analysis 2031

08-17-2022 07:26 AM CET | Health & Medicine

Press release from: Future Market Insights

SGLT2 Inhibitors Treatment Market Current and Future Industry

SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level.

SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetes across the globe is never-ending, thus leading to grow the market. The prevalence of people suffering from Diabetes is said to lead the market at another level.

What is driving Demand for SGLT2 Inhibitors Treatment Market?
The demand for this market has seen at a higher rate at a global level as there has been increase in the number of Diabetic cases with increase in the population. According to WHO data worldwide, the count in the cases is seen at a higher side i.e. from 2.8% in 2000 and by 2030 it is said to be 4.4%. According to the 29.1 million cases of people diagnosing with diabetes in the year 2010.

Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14054

The changing lifestyle, obesity and sedentary lifestyle can be the causes for diabetes can demand the SGLT2 market. Population preferring simple and easy way of treatment can boost the market. Covid 19 has eventually driven the market growth as post covid complications has made it a necessity. In addition, new combination drugs seems to drive the market. US and Europe has the highest number of morbid obesity cases which leads to Diabetes, can be the driving factor for the market.

U.S. SGLT2 Inhibitors Treatment Market Outlook
North America occupies about 65% of the market share. US accounts for the highest number of type 2 diabetic cases owing to demand in the market growth. North America also has well established health a care structure. Canagliflozin saw an immense growth in the US, which was approved by US FDA. According the study on an average of 1.75 million US native is diagnosed with type 2 Diabetes, furthermore the population suffering from morbid obesity is one of the major reason to cause Diabetes. This gives us an open window to drive our market.

Request for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14054

Europe Demand Outlook for SGLT2 Inhibitors Treatment Market
Empagliflozin is said to be the leading the market in Europe region and can be used in adults with low adverse effect. European commission has granted permission to market the product globally. EMPOWER program has been run so as to understand the efficacy of the Empagliflozin, this was brought in by Boehringer Ingelheim and Lilly.

Empagliflozon was the recent medicine to be approved by FDA in 2014. European Medicine Agency confirms that the SGLT 2 inihibitors can be used in treatment of Type 2 Diabetes. Europe has the highest rate of Diabetes cases which is fatal in nature and in the given forecast period it is said to reach an average of 10million cases.

Who are the Key Manufacturers and Suppliers of SGLT2 Inhibitors treatment market
Some of the key players operating in the SGLT2 Inhibitors Treatment Market are

Eli Lilly and Company (The U.S),
C.H. Boehringer Sohn AG & Ko. KG (Germany),
Johnson & Johnson (The U.S),
AstraZeneca plc (UK),
The Merck Group (Germany),
Pfizer Inc. (The U.S),
Tecnimede Group (The U.S),
Unichem Laboratories Ltd. (India), and
Edifício Bluepharma (Portugal).

Request Customization of the report @ https://www.futuremarketinsights.com/customization-available/rep-gb-14054

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Key Segment
By Product Type:
Single Cap
Double Cap
By End User:
Hospitals
Clinics
Diagnostic Centre's
Others
By Application:
Blood Collection,
Blood Transfusion
Infusion
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SGLT2 Inhibitors Treatment Market Current and Future Industry Landscape Analysis 2031 here

News-ID: 2706543 • Views:

More Releases from Future Market Insights

Indoor Air Quality Monitor Market to Reach USD 13.2 Billion by 2035 with Smart and Fixed Devices Driving Growth
Indoor Air Quality Monitor Market to Reach USD 13.2 Billion by 2035 with Smart a …
The indoor air quality (IAQ) monitor market is witnessing robust growth, with an estimated value of USD 5.9 billion in 2025 and a projected rise to USD 13.2 billion by 2035, registering a compound annual growth rate of 8.4%. This expansion is largely driven by increasing awareness of the health impacts of air pollution and growing regulatory emphasis on safe indoor environments. Consumers, industries, and governments alike are recognizing the
Construction Equipment Fleet Management Software Market Set to Surge to USD 21.3 Billion by 2035
Construction Equipment Fleet Management Software Market Set to Surge to USD 21.3 …
The construction equipment fleet management software market is poised for unprecedented growth over the next decade. Valued at USD 5.2 billion in 2025, the market is projected to reach USD 21.3 billion by 2035, registering a remarkable compound annual growth rate of 15.2%. This surge reflects the increasing need for operational efficiency, predictive maintenance, and real-time monitoring across complex construction projects worldwide. Modern construction operations are becoming increasingly digitized. Contractors and
Aluminum Coated Thermal Protective Clothing Market to Reach USD 2.9 billion by 2035 on Innovation and Safety Demand
Aluminum Coated Thermal Protective Clothing Market to Reach USD 2.9 billion by 2 …
The aluminum coated thermal protective clothing market is entering a period of steady growth, reflecting the growing global emphasis on workplace safety and technological innovation in protective apparel. Valued at USD 1.7 billion in 2025, the market is projected to reach USD 2.9 billion by 2035, advancing at a compound annual growth rate of 5.2%. This expansion is underpinned by rising industrial activity, regulatory mandates for occupational safety, and increasing
North America Yoga and Meditation Product Market to Reach USD 41.1 Billion by 2035 Driven by Wearables and At-Home Wellness
North America Yoga and Meditation Product Market to Reach USD 41.1 Billion by 20 …
The North American yoga and meditation product industry is experiencing significant expansion, with a market size estimated at USD 20.7 billion in 2025 and projected to reach USD 41.1 billion by 2035. This growth, reflecting a compound annual growth rate of 7.1%, is fueled by a surge in consumer interest in holistic health, stress management, and lifestyle balance. Rising awareness of mental and physical well-being has accelerated the adoption of

All 5 Releases


More Releases for SGLT

AstraZeneca, Lilly & J&J: Strategic Moves Powering SGLT‐2 Investments | SGLT …
SGLT-2 Inhibitors Market reached US$ 17.95 billion in 2024 and is expected to reach US$ 36.39 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033. The SGLT-2 Inhibitors Market is extensively analyzed in the latest study by DataM Intelligence, delivering a well-rounded assessment backed by reliable statistics, historical data, and strategic insights. This report profiles leading industry players, examining their product offerings, pricing strategies, financial
Antidiabetic SGLT-2 Inhibitor Market Movement-detailed Research Analysis 2023 - …
New Jersey (United States) - Antidiabetic SGLT-2 Inhibitor Market is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share, and contact information are
Antidiabetic Sglt-2 Inhibitor Market Insights, Growth Forecast to 2025
The Global Antidiabetic Sglt-2 Inhibitor Market report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of the Global Market. Global Antidiabetic Sglt-2 Inhibitor Market research report offers extensive research and analysis of key aspects of the global Global Antidiabetic Sglt-2 Inhibitor market. The report on Global Antidiabetic Sglt-2 Inhibitor Market covers big geographical, as well as sub-regions throughout the world. The study
Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Competitive Dynamics …
LP INFORMATION offers a latest published report on Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024,
Antidiabetic SGLT-2 Inhibitor Market Analysis- Size, Share, Growth, Industry Dem …
The Global Antidiabetic SGLT-2 Inhibitor Market Research Report 2017 renders deep perception of the key regional market status of the Antidiabetic SGLT-2 Inhibitor Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan. Request For Sample Of Antidiabetic SGLT-2 Inhibitor Market Research Report @ https://www.qyresearchgroups.com/request-sample/426283 The report on “Global
Global Antidiabetic SGLT-2 Inhibitor Sales Industry Analysis, Growth, Demand, St …
Market Research Hub's report studies sales (consumption) of Global Antidiabetic SGLT-2 Inhibitor market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Anderson Hay & Grain Inc. Border Valley Sanofi Johnson & Johnson Bristol-Myers Squibb AstraZeneca Boehringer Ingelheim GlaxoSmithKline Pfizer Takeda Pharmaceuticals Eli Lilly Merck & Co. Novo Nordisk Request Free Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=942289 Market Segment by Regions, this report splits Global into several key